Mark M Pomerantz

Dana-Farber Cancer Institute Harvard Medical School

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 87 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplemental Figure 3 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Atish D. Choudhury,Lucia Kwak,Alexander Cheung,Kathryn M. Allaire,Jaqueline Marquez,David D. Yang,Abhishek Tripathi,Jacqueline M. Kilar,Meredith Flynn,Brianna Maynard,Rebecca Reichel,Amanda F. Pace,Brandon K. Chen,Eliezer M. Van Allen,Kerry Kilbridge,Xiao X. Wei,Bradley A. McGregor,Mark M. Pomerantz,Rupal S. Bhatt,Christopher J. Sweeney,Glenn J. Bubley,Heather A. Jacene,Mary-Ellen Taplin,Franklin W. Huang,Lauren C. Harshman,Lawrence Fong

crossref（2024）

引用0浏览0引用

Supplementary File 3 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

引用0浏览0引用

Supplemental Figure 8 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

引用0浏览0引用

Supplemental Figure 5 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

引用0浏览0引用

Supplemental Figure 7 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

引用0浏览0引用

Postradical Prostatectomy Prostate-Specific Antigen Outcomes after 6 Versus 18 Months of Perioperative Androgen-Deprivation Therapy in Men with Localized, Unfavorable Intermediate-Risk or High-Risk Prostate Cancer: Results of Part 2 of a Randomized Phase 2 Trial

Rana R. Mckay,Wanling Xie,Xiaoyu Yang,Andres Acosta,Dana Rathkopf,Vincent P. Laudone,Glenn J. Bubley,David J. Einstein,Peter Chang,Andrew A. Wagner,Christopher J. Kane,Mark A. Preston,Kerry Kilbridge,Steven L. Chang,Atish D. Choudhury,Mark M. Pomerantz, Quoc-Dien Trinh,Adam S. Kibel,Mary-Ellen Taplin

CANCERno. 9 (2024): 1629-1641

引用0浏览0WOS引用

Supplemental Figure 4 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

引用0浏览0引用

Supplemental Figure 1 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

引用0浏览0引用

Supplemental Figure 6 from Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

crossref（2024）

引用0浏览0引用

Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer

Konrad H Stopsack,Joseph Vijai, Michael Conry,Jacob E Berchuck,Yelena Kemel,Samantha E Vasselman, Dory A Freeman, Gwo-Shu M Lee,Diana Mandelker,David B Solit,Michael J Morris,Kathryn L Penney,Wassim Abida,Kenneth Offit,Lorelei A Mucci,Philip W Kantoff,Mark M Pomerantz

Clinical cancer research an official journal of the American Association for Cancer Research (2024)

引用0浏览0WOS引用

加载更多

作者统计

#Papers: 88

#Citation: 3603

H-Index: 28

G-Index: 57

Sociability: 7

Diversity: 3

Activity: 66

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn